9lione, Inc.
PrivateLast Round
Series A
Sep 11, 2026
Est. Valuation
$10.76M
Total Funding Raised
$1.83M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
9lione, Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series A round in September 2026.
9lione, Inc. is a healthcare technology company that develops a cloud-based pharmaceutical distribution and inventory management platform to help medical institutions redistribute unused medicines and reduce waste.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Supply Chain, Vertical SaaS, Waste Management
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
9lione, Inc. Comparables
Compare 9lione, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharma Cloud Inc. | 91% | |
| 株式会社ミライシアホールディング | 82% | |
| Kakehashi Inc. | 81% |
For institutional investors. Book with your work email.
9lione, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 11, 2026 | ||||
| Series A Extension | Sep 5, 2026 | ||||
| Series B | Dec 25, 2023 | ||||
| Seed | Jun 30, 2021 | ||||
| Accelerator | Oct 26, 2018 |
For institutional investors. Book with your work email.
9lione, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Open Network Lab | Accelerator |
| DG Ventures | Series A, Series B |
| Yokohama Capital Co., Ltd. | Series B, Series A |
| Mitsui Sumitomo Insurance Capital Co., Ltd. | Series A, Series B |
| Incubate Fund | Series A, Seed |
| GA1号投資組合 | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
$780K round led by Yokohama Capital Co., Ltd.
- Sep 5, 2026
$220K round led by FUNDINNO.
For institutional investors. Book with your work email.
9lione, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 9lione, Inc.'s valuation, stock price, and market status.
Is 9lione, Inc. a public or private company?
9lione, Inc. is a private company.
What is the current stock price of 9lione, Inc.?
9lione, Inc. is a private company, so its shares have no public market price. Caplight tracks 9lione, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 9lione, Inc. worth (valuation)?
9lione, Inc.'s valuation is estimated at $10.8M based on funding round data.
Can I buy 9lione, Inc. stock?
9lione, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 9lione, Inc.'s last funding round?
9lione, Inc.'s most recent funding round was Series A on September 11, 2026.
Who are the main investors in 9lione, Inc.?
Key investors in 9lione, Inc. include Open Network Lab, Yokohama Capital Co., Ltd., Incubate Fund.
Will 9lione, Inc. IPO soon?
No public IPO plans have been announced for 9lione, Inc..
How can I track 9lione, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in 9lione, Inc.'s shares on secondary markets.